JPRN-UMIN000029818
Completed
未知
Intravitreal triamcinolone acetonide combined withccataract surgery for diabetic macular edema - IVTA with cataract for DME
Department of Ophthalmology, Mie University Graduate School of Medicine0 sites30 target enrollmentNovember 4, 2017
Conditionsdiabetic macular edema
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- diabetic macular edema
- Sponsor
- Department of Ophthalmology, Mie University Graduate School of Medicine
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients were excluded if they had the macular traction syndrome, active proliferative diabetic retinopathy, uveitis, poorly controlled ocular hypertension, glaucoma, had intraocular surgery within the past 6 months, and history of anti\-VEGF treatment or STTA, or had macular photocoagulation within the past 3 months before the beginning of the treatment. Patients who had adverse reactions to steroids were also excluded.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Intravitreal Injection of Triamcinolone Acetonide in RetinitisIRCT201104266293N1Tehran University of Medical Sciences161
Completed
Not Applicable
Intravitreal versus subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular oedemaMacular oedemaEye DiseasesISRCTN67086909St Orsola Malpighi University Hospital Bologna (Italy)28
Active, not recruiting
Not Applicable
Triamcinolone Acetonide Intravitreal Injection for the treatment for exudative maculopathy - NDexudative maculopathyMedDRA version: 8.1Level: LLTClassification code 10038862Term: Retinal exudatesEUCTR2006-001727-19-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
Completed
Phase 4
The Use of Intravitreal Injection of Triamcinolone Acetonide in Diabetic Patients to Reduce Diabetic Macular EdemaDiabetic macular edemaEye - Diseases / disorders of the eyeACTRN12613000249752suez canal university hospital19
Completed
Phase 2
Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema that Persists after Laser Treatment (TDMO)Diabetic Macular OedemaMetabolic and Endocrine - DiabetesEye - Diseases / disorders of the eyeACTRN12605000211662Professor Mark Gillies70